日本脳炎ワクチン市場は2023年から2028年に7,569万米ドル、予測期間中のCAGRは6.29%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。同市場は、国家予防接種計画への日本脳炎ワクチンの盛り込み、日本脳炎ワクチン開拓のための戦略的提携、日本脳炎に関する啓蒙キャンペーンの増加などが牽引しています。
本調査では、今後数年間の日本脳炎ワクチン市場成長を牽引する主な要因の一つとして、新規日本脳炎ワクチン技術の開拓を挙げています。また、BRICSによる研究への旺盛な投資やアジアへのインバウンド旅行者の増加も市場の大きな需要につながると思われます。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Japanese encephalitis vaccines market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global japanese encephalitis vaccines market 2018 - 2022 ($ million)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Inactivated vaccines - Market size and forecast 2023-2028
Exhibit 34: Chart on Inactivated vaccines - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Inactivated vaccines - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Inactivated vaccines - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Inactivated vaccines - Year-over-year growth 2023-2028 (%)
6.4 Recombinant vaccines - Market size and forecast 2023-2028
Exhibit 38: Chart on Recombinant vaccines - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Recombinant vaccines - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Recombinant vaccines - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Recombinant vaccines - Year-over-year growth 2023-2028 (%)
6.5 Live attenuated vaccines - Market size and forecast 2023-2028
Exhibit 42: Chart on Live attenuated vaccines - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Live attenuated vaccines - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Live attenuated vaccines - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Live attenuated vaccines - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Type
Exhibit 46: Market opportunity by Type ($ million)
Exhibit 47: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 48: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 49: Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Exhibit 50: Chart on Comparison by Distribution Channel
Exhibit 51: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacy - Market size and forecast 2023-2028
Exhibit 52: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacy - Market size and forecast 2023-2028
Exhibit 56: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
7.5 Online pharmacy - Market size and forecast 2023-2028
Exhibit 60: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 64: Market opportunity by Distribution Channel ($ million)
Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 North America - Market size and forecast 2023-2028
Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 China - Market size and forecast 2023-2028
Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
9.8 India - Market size and forecast 2023-2028
Exhibit 91: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on India - Year-over-year growth 2023-2028 (%)
9.9 Japan - Market size and forecast 2023-2028
Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.10 South Korea - Market size and forecast 2023-2028
Exhibit 99: Chart on South Korea - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on South Korea - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on South Korea - Year-over-year growth 2023-2028 (%)
9.11 Australia - Market size and forecast 2023-2028
Exhibit 103: Chart on Australia - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on Australia - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on Australia - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Australia - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Adimmune Corp.
Exhibit 115: Adimmune Corp. - Overview
Exhibit 116: Adimmune Corp. - Product / Service
Exhibit 117: Adimmune Corp. - Key offerings
12.4 Bharat Biotech Ltd.
Exhibit 118: Bharat Biotech Ltd. - Overview
Exhibit 119: Bharat Biotech Ltd. - Product / Service
Exhibit 120: Bharat Biotech Ltd. - Key news
Exhibit 121: Bharat Biotech Ltd. - Key offerings
12.5 Biological E. Ltd.
Exhibit 122: Biological E. Ltd. - Overview
Exhibit 123: Biological E. Ltd. - Product / Service
Exhibit 124: Biological E. Ltd. - Key offerings
12.6 Medigen Inc.
Exhibit 125: Medigen Inc. - Overview
Exhibit 126: Medigen Inc. - Product / Service
Exhibit 127: Medigen Inc. - Key offerings
12.7 Meiji Holdings Co. Ltd.
Exhibit 128: Meiji Holdings Co. Ltd. - Overview
Exhibit 129: Meiji Holdings Co. Ltd. - Business segments
Exhibit 130: Meiji Holdings Co. Ltd. - Key news
Exhibit 131: Meiji Holdings Co. Ltd. - Key offerings
Exhibit 132: Meiji Holdings Co. Ltd. - Segment focus
12.8 Panacea Biotec Ltd.
Exhibit 133: Panacea Biotec Ltd. - Overview
Exhibit 134: Panacea Biotec Ltd. - Product / Service
Exhibit 135: Panacea Biotec Ltd. - Key offerings
12.9 Sanofi SA
Exhibit 136: Sanofi SA - Overview
Exhibit 137: Sanofi SA - Business segments
Exhibit 138: Sanofi SA - Key news
Exhibit 139: Sanofi SA - Key offerings
Exhibit 140: Sanofi SA - Segment focus
12.10 Shandong Hengye Biotechnology Co. Ltd.
Exhibit 141: Shandong Hengye Biotechnology Co. Ltd. - Overview
Exhibit 142: Shandong Hengye Biotechnology Co. Ltd. - Product / Service
Exhibit 143: Shandong Hengye Biotechnology Co. Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 144: Inclusions checklist
Exhibit 145: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 146: Currency conversion rates for US$
13.4 Research methodology
Exhibit 147: Research methodology
Exhibit 148: Validation techniques employed for market sizing
Exhibit 149: Information sources
13.5 List of abbreviations
Exhibit 150: List of abbreviations
